Teva Pharmaceuticals: Carl Batt

Carl Batt has been the Chief Financial Officer of South Africa and sub-Saharan Africa at Teva Pharmaceuticals since July 2016.

Carl Batt has been in the pharmaceutical business for over 14 years, working at Allergan for 12 of those years before joining Teva Pharmaceuticals. He served as both Head of Finance and Group Financial Manager for Allergan. Prior to that, he was the Divisional Financial Director of Stantronic Group Holdings. He started his career as an Assistant Accountant at Standard Bank Group and, after a year, became an Accountant at Arthur Andersen & Co. He has both a B.Com and B.Compt degree in Accounting from UJ and UNISA respectively. He was appointed CFO of Teva in July 2016.

Work
2016 – Present    Chief Financial Officer, South Africa and Sub-Sahara Africa,                                          Teva Pharmaceuticals 
2016 – 2016         Head of Finance, Generics, Allergan
2004 – 2016         Group Financial Manager, Allergan
1994 – 2002         Divisional Financial Director, Stantronic Group Holdings Ltd
1992 – 1994         Accounting, Auditing, Arthur Andersen & Co. 
1991 – 1992         Assistant Accountant, Standard Bank Group 

Education
2015                       Commissioner of Oaths
2015                       South African Institute of Tax Professionals
2010 – 2014         B.Compt, Accounting, UNISA
1989 – 1991         B.Com, Accounting, UJ
1981 – 1985         Matric, DF Malan High School

About Teva Pharmaceuticals: Teva Pharmaceuticals develop, produce and market affordable, high-quality generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. They have a portfolio of more than 1800 molecules, and produce approximately 120 billion tablets and capsules a year at 80 manufacturing facilities. They rank among the leading pharmaceutical companies in the world and are active in 80 countries with approximately 50 000 employees.